Knox-Macaulay H H, Weatherall D J, Clegg J B, Pembrey M E
Br Med J. 1973 Jul 21;3(5872):150-5. doi: 10.1136/bmj.3.5872.150.
Different forms of thalassaemia or related disorders were found in 116 people of apparently pure British stock. Among them were one family with a child homozygous for beta-thalassaemia and eight heterozygous relatives, 16 families with 83 persons heterozygous for beta-thalassaemia, two families with three persons with Hb H disease and three heterozygous for alpha-thalassaemia 1, one family with a child apparently homozygous for the "silent beta-thalassaemia gene," one family with six members heterozygous for a form of beta-thalassaemia intermedia, and three families with 11 members heterozygous for different types of hereditary persistence of fetal haemoglobin. The clinical, haematological, and haemoglobin biosynthetic findings in these persons were similar to those of patients with thalassaemia from other racial groups. The heterozygous state for beta-thalassaemia is overlooked in British patients, particularly during pregnancy, because it is not considered in the differential diagnosis of refractory anaemia. In many cases this leads to much unnecessary investigation and potentially harmful treatment.There seem to be several varieties of hereditary persistence of fetal haemoglobin production among British people. These conditions, while not causing anaemia, may cause difficulties during examination of maternal blood for fetal cells and may, if inherited with a beta-thalassaemia gene, produce an unusually high level of Hb F in a person heterozygous for beta-thalassaemia.
在116名明显为纯正英国血统的人中发现了不同形式的地中海贫血或相关疾病。其中有一个家庭,其孩子为β地中海贫血纯合子,还有8名杂合子亲属;16个家庭,共83人是β地中海贫血杂合子;两个家庭,有3人患血红蛋白H病,3人是α地中海贫血1杂合子;一个家庭,其孩子显然是“静止型β地中海贫血基因”纯合子;一个家庭,有6名成员是中间型β地中海贫血杂合子;还有3个家庭,共11名成员是不同类型胎儿血红蛋白遗传性持续存在的杂合子。这些人的临床、血液学和血红蛋白生物合成结果与其他种族群体的地中海贫血患者相似。在英国患者中,β地中海贫血杂合子状态常被忽视,尤其是在孕期,因为在难治性贫血的鉴别诊断中未考虑到这一点。在许多情况下,这会导致许多不必要的检查和潜在的有害治疗。在英国人中似乎存在几种胎儿血红蛋白产生遗传性持续存在的类型。这些情况虽然不会导致贫血,但在检测母血中的胎儿细胞时可能会造成困难,并且如果与β地中海贫血基因一起遗传,可能会使β地中海贫血杂合子个体的胎儿血红蛋白水平异常升高。